A detailed history of Morgan Stanley transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 111,511 shares of IGMS stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111,511
Previous 101,095 10.3%
Holding current value
$1.99 Million
Previous $975,000 21.44%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024

BUY
$6.51 - $11.47 $67,808 - $119,471
10,416 Added 10.3%
111,511 $766,000
Q2 2024

Aug 14, 2024

BUY
$6.51 - $11.47 $67,808 - $119,471
10,416 Added 10.3%
111,511 $766,000
Q1 2024

Oct 17, 2024

SELL
$8.68 - $17.36 $90,410 - $180,821
-10,416 Reduced 9.34%
101,095 $975,000
Q1 2024

Aug 16, 2024

BUY
$8.68 - $17.36 $52,548 - $105,097
6,054 Added 6.37%
101,095 $975,000
Q1 2024

May 15, 2024

BUY
$8.68 - $17.36 $52,548 - $105,097
6,054 Added 6.37%
101,095 $975,000
Q4 2023

Aug 16, 2024

SELL
$3.94 - $8.79 $64,891 - $144,771
-16,470 Reduced 14.77%
95,041 $789,000
Q4 2023

Feb 13, 2024

BUY
$3.94 - $8.79 $83,713 - $186,761
21,247 Added 28.79%
95,041 $789,000
Q3 2023

Nov 15, 2023

SELL
$6.66 - $10.64 $174,105 - $278,150
-26,142 Reduced 26.16%
73,794 $616,000
Q2 2023

Aug 14, 2023

BUY
$8.86 - $14.0 $161,712 - $255,528
18,252 Added 22.34%
99,936 $922,000
Q1 2023

May 15, 2023

SELL
$13.74 - $25.76 $138,128 - $258,965
-10,053 Reduced 10.96%
81,684 $1.12 Million
Q4 2022

Feb 14, 2023

SELL
$15.45 - $26.02 $127,555 - $214,821
-8,256 Reduced 8.26%
91,737 $1.56 Million
Q3 2022

Nov 14, 2022

SELL
$15.42 - $27.01 $387,797 - $679,274
-25,149 Reduced 20.1%
99,993 $2.27 Million
Q2 2022

Oct 27, 2022

BUY
$13.27 - $25.5 $378,885 - $728,076
28,552 Added 29.56%
125,142 $2.26 Million
Q2 2022

Aug 15, 2022

BUY
$13.27 - $25.5 $378,885 - $728,076
28,552 Added 29.56%
125,142 $2.26 Million
Q1 2022

Oct 27, 2022

SELL
$13.42 - $29.73 $383,167 - $848,850
-28,552 Reduced 22.82%
96,590 $2.58 Million
Q1 2022

May 13, 2022

BUY
$13.42 - $29.73 $612,099 - $1.36 Million
45,611 Added 89.47%
96,590 $2.58 Million
Q4 2021

Feb 14, 2022

BUY
$27.59 - $66.39 $153,427 - $369,194
5,561 Added 12.24%
50,979 $1.5 Million
Q3 2021

Nov 15, 2021

BUY
$65.76 - $90.65 $2.99 Million - $4.12 Million
45,418 New
45,418 $2.99 Million

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $517M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.